Zhejiang AngLiKang Pharmaceutical CO.,LTD. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 338.21 million compared to CNY 318.88 million a year ago. Revenue was CNY 338.21 million compared to CNY 318.88 million a year ago.

Net income was CNY 39.09 million compared to CNY 32.78 million a year ago. Basic earnings per share from continuing operations was CNY 0.2828 compared to CNY 0.2345 a year ago. Diluted earnings per share from continuing operations was CNY 0.2828 compared to CNY 0.2345 a year ago.